Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/2000
07/04/2000US6083756 Identifying infant's susceptibility by detecting helicobacter pylori in sample of blood, saliva, dental plaque, feces or exhaled air collected from infant's mother, close relative, or person expected to come into close bodily contact
07/04/2000US6083746 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells
07/04/2000US6083745 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells
07/04/2000US6083720 Dodecahedral adenoviral protein complex, composition containing same and uses thereof
07/04/2000US6083719 Cytidine deaminase cDNA as a positive selectable marker for gene transfer, gene therapy and protein synthesis
07/04/2000US6083713 Nucleotide sequences coding binding polypeptide for the terminal domain of the amyloid precursor protein; for the diagnosis and design of drugs for treatment of alzheimer's disease
07/04/2000US6083706 Inhibitors of leaderless protein export
07/04/2000US6083536 Super-critical lipid extract from mussels having anti-inflammatory activity
07/04/2000US6083532 Tablets for sustained release of drugs and gelling polymer
07/04/2000US6083531 Fast disintegrating oral dosage form
07/04/2000US6083528 Self administering for hormone replacement therapy
07/04/2000US6083526 Use of isoflavonoids in the treatment or prevention of postpartum depression
07/04/2000US6083525 Carriers and masking agents for deodorizing
07/04/2000US6083518 Bactericide cleaning compounds with surfactants
07/04/2000US6083515 Treating inflammation, pain, gastrointestinal lesions or fever in an animal in need thereof with reduction of the gastrointestinal toxicity or renal toxicity of the nonsteroidal antiinflammatory drug
07/04/2000US6083507 Composition for the elimination of hasmifl toxin buildup comprising quantities of gotu-kola, whole leaf aloe-vera, lactobacilli organism and folic acid
07/04/2000US6083505 Immunogen/vaccine adjuvant composition containing an immunogen in an amount effective to stimulate an immune response and as a vaccine adjuvant a 1h-imidazo(4,5-c)quinolin-4-amine in an amount effective to increase the immune response to the
07/04/2000US6083502 Methods for detecting the antigen and its expression level as an indication of the presence of tumor cells
07/04/2000US6083497 Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers
07/04/2000US6083495 Method of making phosphate-binding polymers for oral administration
07/04/2000US6083488 Barrier to plaque formation
07/04/2000US6083483 For the modulation of the motility and peristalsis of the hollow organs of the urogenital and gastrointestinal tract
07/04/2000US6083408 Depth-type filter for killing microorganisms and inactivating viruses which comprises a fibrous material and crospovidone-iodine and its use
07/04/2000CA2169356C Phosphate-binding polymers for oral administration
07/04/2000CA2124792C Methods for the treatment of osteoporosis using bisphosphonates and parathyroid hormone
07/04/2000CA2116565C Low speed model following velocity command system for rotary wing aircraft
07/04/2000CA2067374C Osteogenesis promoter
07/04/2000CA2025212C (2-imidazolin-2-ylamino) tetrahydroquinoxalines and methods for using same
07/04/2000CA2002337C Controlled release flecainide acetate formulation
07/04/2000CA1341046C Cycloalkyl-substituted glutaramide antihypertensive agents
07/04/2000CA1341044C Benzopyrido piperidine, piperidylidene and peperazine compounds, compositions, methods of manufacture and methods of use
07/04/2000CA1341043C Piperazinyl derivatives of purines and isosteres thereof as hypoglycemic agents
06/2000
06/30/2000CA2293890A1 A novel treatment for pre-eclampsia and related diseases
06/29/2000WO2000037943A1 Diagnosis of sepsis using the lps-binding moiety of alkaline phosphatase
06/29/2000WO2000037927A1 High energy phototherapeutic agents
06/29/2000WO2000037685A2 Method of identifying a psychotropic agent using differential gene expression
06/29/2000WO2000037643A2 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
06/29/2000WO2000037640A2 Compositions and methods for the treatment of tumor
06/29/2000WO2000037616A1 Compounds, methods of screening and methods of treatment for central and peripheral nervous system disorders
06/29/2000WO2000037613A2 Human akt-3
06/29/2000WO2000037612A1 SOMATIC CELLS WITH ABLATED Prp GENE AND METHODS OF USE
06/29/2000WO2000037490A2 Outer surface proteins, their genes, and their use
06/29/2000WO2000037481A1 BRAIN CELL OR NERVE CELL-PROTECTIVE AGENTS COMPRISING GINSENOSIDE Rb¿1?
06/29/2000WO2000037477A1 Organo-phosphorus compounds and their utilization
06/29/2000WO2000037474A1 Fused 1,2,4-thiadiazine derivatives, their preparation and use
06/29/2000WO2000037473A1 Epothilone derivatives and their use as antitumor agents
06/29/2000WO2000037472A2 Substituted pirroloindoles
06/29/2000WO2000037470A1 Antihistaminic spiro compounds
06/29/2000WO2000037469A2 Process for preparing n6-substituted deaza-adenosine derivatives
06/29/2000WO2000037468A1 DIBENZO[a,g]QUINOLIZINIUM DERIVATIVES AND THE SALTS THEREOF
06/29/2000WO2000037467A1 1,8-benzonaphthyridine derivatives
06/29/2000WO2000037466A1 BENZISOXAZOLES AND PHENONES AS α2-ANTAGONISTS
06/29/2000WO2000037464A2 4-(aminoalkoxy)benzofurans as n-myristoyltransferase inhibitors
06/29/2000WO2000037463A1 S-oxide lipid lowering compounds
06/29/2000WO2000037462A1 Non-peptide nk1 receptors antagonists
06/29/2000WO2000037461A1 4-(aminomethyl)-piperidine benzamides for treating gastrointestinal disorders
06/29/2000WO2000037459A1 Tricyclic farnesyl protein transferase inhibitors
06/29/2000WO2000037458A1 Farnesyl protein transferase inhibitors
06/29/2000WO2000037456A1 Amide and urea derivatives as 5-ht reuptake inhibitors and as 5-ht1b/1d ligands
06/29/2000WO2000037455A1 Benzothiepin-anilide derivatives, their production and their use for antagonizing ccr-5
06/29/2000WO2000037452A1 Sulphonyloxazolamines as therapeutic active ingredients
06/29/2000WO2000037451A1 Il-5 inhibiting 6-azauracil derivatives
06/29/2000WO2000037450A1 NEW β-AMIDE AND β-SULFONAMIDE CARBOXYLIC ACID DERIVATIVES, THEIR PREPARATION AND THEIR USE AS ENDOTHELIN RECEPTOR ANTAGONISTS
06/29/2000WO2000037447A1 9-aminoacridine derivatives and process for the preparation thereof
06/29/2000WO2000037441A1 Melatonin derivatives and medicine containing same
06/29/2000WO2000037438A1 Novel thio-aminotetralin compounds useful in pain management
06/29/2000WO2000037436A1 Sulfonamide hydroxamates
06/29/2000WO2000037430A2 Use of androgen receptor suppressors
06/29/2000WO2000037429A2 INHIBITORS OF α4β1 MEDIATED CELL ADHESION
06/29/2000WO2000037426A1 Novel oxo-aminotetralin compounds useful in pain management
06/29/2000WO2000037423A1 Substituted 2-phenyl-1-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them
06/29/2000WO2000037422A2 Ion channel modulating agents
06/29/2000WO2000037421A1 Nephronin: a series of compounds for treatment of infectious diseases and cancer
06/29/2000WO2000037358A1 NOVEL sPLA2 INHIBITORS
06/29/2000WO2000037141A1 Combination chemotherapy
06/29/2000WO2000037124A1 Injectable hyaluronic acid derivative with pharmaceuticals/cells
06/29/2000WO2000037110A2 Ribavirin-pegylated interferon alfa induction hcv combination therapy
06/29/2000WO2000037109A2 Clathrates of dehydroepiandrosterone and corresponding pharmaceutical compositions
06/29/2000WO2000037108A1 Oil-in-water emulsion exhibiting a protective action against damages to human organs resulting from peroxidation, and the production and use thereof
06/29/2000WO2000037107A2 Use of cyclooxygenase-2 inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combination treatment of neoplasia
06/29/2000WO2000037093A1 Bone resorption inhibitors
06/29/2000WO2000037090A1 Medicaments for the treatment of lung infections
06/29/2000WO2000037089A1 Cyclic adenosine diphosphate ribose analogues for modulating t cell activity
06/29/2000WO2000037088A1 Use of etherlysophospholipids as antiinflammatory agents
06/29/2000WO2000037085A1 Treatment of diseases involving cyst formation
06/29/2000WO2000037084A1 Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma
06/29/2000WO2000037083A1 Oral antiestrogen pharmaceutical composition
06/29/2000WO2000037082A1 Use of 5-ht7 receptor antagonists for treating neuronal degeneration resulting from ischemic events
06/29/2000WO2000037081A1 Novel formulation
06/29/2000WO2000037080A1 Ophthalmic compositions comprising pheniramine and povidone
06/29/2000WO2000037079A1 Ophtalmic compositions comprising pheniramine and a demulcent such as pvp
06/29/2000WO2000037078A1 Combination of cerivastatin and fibrates
06/29/2000WO2000037077A1 Assays for ligands for nuclear receptors
06/29/2000WO2000037076A1 Combinations of farnesyl transferase inhibitors and irinotecan or camptothecin for treating cancer
06/29/2000WO2000037073A1 Use of 5ht3-receptor antagonists for the treatment of chronic fatigue syndrome
06/29/2000WO2000037072A1 Use of inhibitors of gag synthesis for the treatment of corneal haze
06/29/2000WO2000037071A1 Topical treatment of skin disease
06/29/2000WO2000037070A1 Preventive for respiratory infectious diseases
06/29/2000WO2000037068A1 Use of a 5ht2a and 5ht2a/c receptor antagonist for preparing medicines for treating snoring and high resistance syndrome of upper anatomical airways
06/29/2000WO2000037067A2 Sensitizing agents for the treatment of skin lesions
1 ... 6290 6291 6292 6293 6294 6295 6296 6297 6298 6299 6300 6301 6302 6303 6304 6305 6306 6307 6308 6309 6310 ... 7860